Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine Withdrawal Effects on Migraine
NCT03022838Phase 3Terminated
- Sponsor
- Nordlandssykehuset
- Start
- Feb 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caffeine in migraine, sponsored by Nordlandssykehuset. Started Feb 2017; status: terminated.
02
Drugs
caffeine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03022838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03022838.